Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

Despite a tumultuous year of changes and proposed changes to the way the federal government invests in scientific research, the director of the National Cancer Institute, Anthony Letai, MD, PhD, sees ...